Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Anjo JP Veerman"'
Autor:
Salsabila Sandi, Eddy Supriyadi, Ignatius Purwanto, Pudjo Hagung Widjajanto, Inggar Armytasari, Julie Ritter, Anjo JP Veerman
Publikováno v:
Paediatrica Indonesiana, Vol 63, Iss 4, Pp 226-37 (2023)
Background The global burden of childhood cancer is poorly quantified, but it is estimated that 80% of all children with cancer live in low- and middle-income countries with cure rates of childhood cancer far lower than in high-income nations. Obj
Externí odkaz:
https://doaj.org/article/ecdd868bfc084f27b01834c7e8a534dd
Background: In 2001, Dr. Sardjito Hospital initiated a systematic hospital-based registry, Yogyakarta Pediatric Cancer Registry (YPCR). This study aims to present an epidemiological profile of childhood malignancies diagnosed in Dr. Sardjito General
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0efffbcb40c9ef7277d8acd82b7ad40
https://doi.org/10.22541/au.166574345.58282938/v1
https://doi.org/10.22541/au.166574345.58282938/v1
Autor:
Sutaryo Sutaryo, Pudjo Widjajanto, Sri Mulatsih, Bambang Ardianto, Alexandra Pangarso, Eddy Supriyadi, Ignatius Purwanto, Claudia Adelin, Rahmadani Lestari, Lintang Sagoro, Scolastika Kristian, Dea Sabrina, Natasha Verena, Arjenne Kors, Gertjan Kaspers, Anjo JP Veerman
Background: As in LMICs, the prognosis of childhood ALL in Indonesia was lower than in HICs. Indonesian-ALL2013 protocol resulted in more toxicities and abandonments than expected. Therefore, it was modified into a pilot ALL2016 protocol. Changes to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa56c83c5740156e270f11f0fa4d0849
https://doi.org/10.22541/au.163734720.08810370/v1
https://doi.org/10.22541/au.163734720.08810370/v1
Autor:
Pieters R, Lf, Thompson, Gj, Broekema, Dr, Huismans, Gj, Peters, St, Pals, Horst E, Hählen K, Anjo JP Veerman
Publikováno v:
Europe PubMed Central
Ecto-5′nucleotidase (5′NT; CD73) expression was studied with a monoclonal antibody (7G2) and a radiochemical assay and compared with the expression of other antigens in B-cell-lineage leukemias on cells from 100 leukemic patients and two cell lin
Autor:
Cm, Zwaan, Gj, Kaspers, Pieters R, Nl, Ramakers-Van Woerden, Ml, Den Boer, Wünsche R, Mm, Rottier, Hählen K, Er, Wering, Ge, Janka-Schaub, Creutzig U, Anjo JP Veerman
Publikováno v:
Europe PubMed Central
Determining in vitro drug resistance may reveal clinically relevant information in childhood leukemia. Using the methyl-thiazol-tetrazolium assay, the resistance of untreated leukemic cells to 21 drugs was compared in 128 children with acute myeloid
Autor:
Mg, Rots, Pieters R, Gj, Peters, Ch, Zantwijk, Mauritz R, Noordhuis P, Jc, Willey, Hählen K, Creutzig U, Janka-Schaub G, Gj, Kaspers, Anjo JP Veerman, Jansen G
Publikováno v:
Europe PubMed Central
Cellular methotrexate (MTX) resistance may cause treatment failure in childhood common/preB-acute lymphoblastic leukemia (c/preB-ALL), T-lineage ALL (T-ALL), and acute myeloid leukemia (AML). The ex vivo potency of several antifolates (MTX, trimetrex
Autor:
Mg, Rots, Pieters R, Gj, Peters, Noordhuis P, Ch, Zantwijk, Gj, Kaspers, Hählen K, Creutzig U, Anjo JP Veerman, Jansen G
Publikováno v:
Europe PubMed Central
Inefficient polyglutamylation is a mechanism of resistance to methotrexate (MTX) in childhood T-lineage acute lymphoblastic leukemia (T-ALL) and in acute myeloid leukemia (AML) in comparison with childhood c/preB-ALL. We analyzed the profile of MTX p
Autor:
Mauritz R, Mw, Bekkenk, Mg, Rots, Pieters R, Mini E, Ch, Zantwijk, Anjo JP Veerman, Gj, Peters, Jansen G
Publikováno v:
Europe PubMed Central
Leukemic cells of 27 children [14 patients with initial acute lymphoblastic leukemia (iALL), 8 patients with relapsed ALL (rALL), and 5 patients with acute nonlymphoblastic leukemia (ANLL)] were evaluated for their sensitivity to methotrexate (MTX) a
Autor:
Klumper E, Giaccone G, Pieters R, Broekema G, van Ark-Otte J, Er, Wering, Gj, Kaspers, Anjo JP Veerman
Publikováno v:
Europe PubMed Central
Previously, we showed that in vitro resistance to daunorubicin (DNR) at initial diagnosis was related to a poor long-term clinical outcome in childhood acute lymphoblastic leukemia (ALL), and that cells of relapsed ALL were in vitro more resistant to
Publikováno v:
Europe PubMed Central
DNA hyperdiploidy is a favorable prognostic factor in childhood acute lymphoblastic leukemia (ALL). The explanation for this prognostic significance is largely unknown. We have studied whether DNA ploidy was related to cellular resistance to 12 drugs